Welcome. If you're a registered user, please log-in. If not, please sign-up.
Change Language
CIS Pharmaceutical Forum

The 1 and Only Conference Covering the Entire CIS Pharmaceutical Sector
CIS Pharmaceutical Conference 2015
Andrey Potapov General Director of Takeda Russia, Area Head of CIS Takeda Pharmaceuticals
Botagoz Smagulova Head of Pharmaceutical Inspectorate, Medical and Pharmaceutical Activity Control Committee Ministry of Health, Kazakhstan
Khabibulla Djalilov Head of the Central Directorate on Quality Control of Pharmaceuticals and Medical Equipment Ministry of Health, Uzbekistan
Vasiliy Boytsov Director, Technical Regulation & Accreditation Dept Eurasian Economic Commission
Regular attendies of the CIS Pharmaceutical Forum
Sponsorship Opportunities CIS Pharmaceutical Forum
Key Regulators

Our forums traditionally gather top representatives of key regulatory bodies of the major CIS pharma markets.

10 February - Circulation of Drugs within the Customs Union and EEU

Hear from key regulators and industry players

Detailed analysis of national markets

The overview of current pharma market trends will cover Kazakhstan, Uzbekistan, Moldova, Belarus, Armenia, Azerbaijan, Kyrgyzstan, Tajikistan, Georgia.

The Drug Manufacturing in Russia & CIS

Discuss Localisation, Inspectorate, State Pharmacopoeia, Quality control, Falsifications at 1-day event on 10 February 2015

The One and Only Conference Covering the Entire CIS Pharmaceutical Sector

What is on offer at the CIS Pharmaceutical Forum in 2015?

ANALYTICAL PRESENTATION: “CURRENT TRENDS IN THE CIS PHARMACEUTICAL INDUSTRY” – will present a comprehensive review of pharmaceutical industry trends in CIS countries

National Markets: EVALUATION OF DEVELOPMENT PROSPECTS FOR CIS PHARMACEUTICAL MARKETS. Overview of the evolution and potential of the pharmaceutical sector in CIS countries: Kazakhstan, Uzbekistan, Moldova, Belarus, Armenia, Azerbaijan, Georgia, Kyrgyzstan, Tajikistan, Turkmenistan

REALITIES OF MARKET ACCESS TO CIS MARKETS. Analysis of the specifics of gaining access for a drug to a CIS market

ROUND -TABLES ON THE TOPIC OF DRUG REGISTRATION- this discussion will allow participants to uncover existing opportunities, and discuss how ongoing and future developments may affect the drug registration procedure. Each round-table will be moderated by a representative of a regulatory body responsible for  drug registration.

COOPERATION BETWEEN MANUFACTURERS, DISTRIBUTORS AND RETAILERS: REGIONAL SPECIFICS. Which factors affect pharmaceutical manufacturers’ choice of distribution channels?

DOMESTIC PRODUCTIONOpportunities for partnership projects

CIS Pharmaceutical Forum in facts and figures:

  • The only event for leading professionals involved in developing CIS pharmaceutical markets
  • 4 information-filled days covering all issues related to the sector’s development
  • 15+ informative plenary sessions & panel discussions with the SECTOR'S LEADERS and KEY REGULATORS
  • 50+ expert speakers will analyse and discuss the most important tasks facing the sector today
  • 250+ CIS pharmaceutical executives, professionals and experts under one roof!
  • 5* event – given ASC’s outstanding experience in organizing conferences for pharmaceutical sector

How to get involved in this exclusive event:

If you are interested in SPEAKING OPPORTUNITIES at the Forum or would like to suggest a topic, please contact Inna Kuzmina at innak@adamsmithconferences.com or on + 44 (0) 207 0176599.

To find out more about SPONSORSHIP OR EXHIBITION POSSIBILITIES at the Forum, please contact Rebecca Pickering on +44 20 7017 7446 or write to rebecca@adamsmithconferences.com

Forum's New Structure in 2015


Unique opportunity to choose and register for one of two parallel events.

  • Focus day “Circulation of drugs within the Customs Union and the Eurasian Economic Union” View programme>>

  • Conference «Drug Manufacturing in Russia & CIS»  View programme>>

! Participants are free to move between the sessions of these events

11TH - 13TH FEBRUARY 2015 - Main Forum
  • 11th of February: Analysis of current priorities and tasks for multinational companies working in CIS countries. ANALITICAL OVERWIEW of CIS markets. Development prospects for CIS markets, countries’ specific characteristics and emerging trends. NATIONAL MARKETS: the Republic of Kazakhstan and the Republic of Uzbekistan
  • 12th of February: NATIONAL MARKETS: Belarus, Moldova, Azerbaijan, Armenia, Special teleconference  - Georgia, Kyrgyzstan, Tajikistan. Regulatory and legal aspects of regulating CIS pharmaceutical markets. REGISTRATION MECHANISMS and  pharmacovigilance of medicines in CIS countries. Country round-tables on the topic of drug registration
  • 13th of February: Distribution.Retail. Domestic Production – Opportunities for partnership projects
Agenda at a glance>>

Mobile Networking App

Mobile Networking App


Get it on iOS

Get it on Android

Desktop Version

User instructions
  • Contact delegates and speakers directly via their personal emails!
  • Arrange meetings
  • View conference programme

Available for registered participants on iOS, Android, Windows, Mac, BlackBerry.

Don't just take our word for it...

«Good selection of topics», Karsten Schlemm, Senior Vice President CEE/CEO Russia, Merz Austria GmbH

«Very interesting exercise to cross borders in thinking and looking at the future», Antonella Segu, Managing Director, PH&T S.p.A.

«Nice opportunity to connect information about the tendency during short period of time», Aelita Reva, Marketing Director, Sopharma PLC

«Quite complete coverage of main Pharma issues», Ludovic Prevost, Engagement Manager, IMS Health

"Mandatory for all CIS pharma players", Shailesh Chavan, General Manager, Getz Pharma International

List of registered companies includes:

Abbott Laboratories GmbH Accovion Actelion Pharmaceuticals Ltd AEQUO Law Firm Akrikhin Alfa Wassermann Alkaloid Skopje Arterium Corporation Astellas Pharma Europe B.V. Astra Pharma
AstraZeneca Russia AvroMed Baker & McKenzie CIS Ltd Baxter ZAO Bayer Bayer Consumer Care AG Bayer KAZ TOO Bayer ZAO Belkozin Luzhskiy Zavod OAO Biologische Heilmittel Heel GmbH
BioTekhpreparat BIOVIT Bristol-Myers Squibb Chemo Lugano SA Chiesi Pharmaceuticals GmbH Dexcel Pharma Dita EstFarm Dori-Darmon Dosfarm TOO EVER Neuro Pharma GmbH
EXAMON Handelsges.m.b.H. Fresenius Kabi LLC Galenpharm Gedeon Richter Polska Sp. z o.o. Gedeon Richter Plc.,Moscow Glenmark Pharmaceuticals Ltd IMS Health Interis Insurance Broker InterLek IPSEN
Janssen Kazakhstan Janssen/Johnson & Johnson Johnson & Johnson LLC Johnson & Johnson, Healthcare Jurabek Laboratories KRKA, d.d., Novo Mesto Liqvor Pharmaceuticals Medis ehf Medportal Merck LLC
Merck Serono Microgen FGUP NPO Moscow Endocrine Plant Nearmedic Nobel Almaty Pharmaceutical Factory Nobel pharmaceuticals Novartis Consumer Health Novartis Oncology Novartis Pharma Services Inc. NV Holding
Nycomed/Takeda Company Orion Corporation Finland Petrovax Pharm NPO Pfizer Kazakhstan Pfizer LLC Pharmagate LLC Pharmasyntez OAO Polpharma SA Polysan NTFF Promo-Med, LLC
Ranbaxy Laboratories Ltd Reckitt Benckiser R-Pharm Sanofi Sanofi-Aventis Group Sensitech EMEA Servier, Les Laboratoires SK-Pharmaceuticals Sona-Pharm Stada CIS
Takeda Osteurope Holding GmbH Takeda Pharmaceuticals Takeda Russia-CIS Thomson Reuters SA Toshkent Viloyati Dori-Darmon Valeant/Jelfa Valenta Asia TOO

Related Events

Adam Smith Conferences’ 2nd International

Turkish Pharmaceutical Forum

October 2015
Intercontinental İstanbul, Türkiye

Adam Smith Conferences' 8th annual

Ukrainian Pharmaceutical Forum

October 2015
InterContinental Hotel, Kyiv, Ukraine


Lead Partner




Supporting Organisations


General Media Partner


Media Partners